Target intelligence / Profile preview

Hemoglobin synthesis pathway and iron homeostasis

Molecular classification
Other (pathway), Enzyme (components), Transporter (components), Receptor (components, e.g., transferrin receptor)
01

Overview

The hemoglobin synthesis pathway and iron homeostasis describe the series of molecular and cellular processes required for delivering iron to developing erythrocytes, its incorporation into heme, and subsequent assembly into the hemoglobin molecule. Iron is transported in blood bound to transferrin, taken up by erythroid precursors via the transferrin receptor, and inserted into protoporphyrin IX by ferrochelatase to generate heme, with tight regulation at several enzymatic and transport steps. Cellular and systemic iron storage involves proteins such as ferritin and processes mediated by hepcidin, ferroportin, and various import/export transporters; dysregulation leads to a spectrum of clinical disorders including anemia, sideroblastic anemia, and iron overload syndromes. Therapeutic strategies often target iron availability, iron transport/storage proteins, or the regulators in this pathway.

Other names
Iron metabolism pathwayIron stores regulationErythropoiesis iron pathwayHeme synthesis pathway
02

Mechanism of action

Iron chelation (removing/binding excess iron); Modulation of iron absorption and release (e.g. via hepcidin, ferroportin); Promotion of erythropoiesis; Altering expression/activity of enzymes/transporter proteins in the pathway

03

Biological functions

Hemoglobin synthesisOxygen transportErythropoiesisIron storage and mobilizationCellular respiration and metabolism
04

Disease associations

AnemiaIron-deficiency disordersThalassemiaSideroblastic anemiaIron overload disorders (hemochromatosis)Cancer (dysregulation of iron metabolism)
05

Safety considerations

Iron deficiency and iron overloadOrgan toxicity (e.g. liver, heart, kidney due to iron overload)Risk of infection (iron as growth factor for pathogens)Adverse drug reactions (e.g. nephrotoxicity, hypersensitivity with chelators)
06

Interacting drugs

Iron chelators (deferoxamine, deferiprone, deferasirox)

3 more in the full profile.

07

Biomarkers

Ferritin (iron stores)Transferrin saturationSerum ironHemoglobin levelsHepcidinReticulocyte count

Beyond the preview

Go deeper on Hemoglobin synthesis pathway and iron homeostasis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemoglobin synthesis pathway and iron homeostasis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call